Drug resistance and its clinical circumvention
Drug resistance and its clinical circumvention Jeffrey A. Moscow, MD Kenneth H. Cowan, MD, PhD Branimir I. Sikic, MD Overview Tumors initially sensitive to chemotherapeutic agents frequently develop resistance to…
Cancer cell immortality: targeting telomerase
Cancer cell immortality: targeting telomerase Ilgen Mender PhD Zeliha Gunnur Dikmen MD, PhD Woodring E. Wright MD, PhD Jerry W. Shay PhD Overview Finding specific targeted agents for cancer therapy…
Coagulopathic complications of cancer patients
Coagulopathic complications of cancer patients Maria T. De Sancho, MD, MSc Jacob H. Rand, MD Overview Bleeding and thrombotic complications are common in cancer patients. The bleeding complications usually result…
